ahlam1399
09-24-2016, 02:21 AM
FDA approves Amgen?s copy of AbbVie arthritis drug Humira
WASHINGTON (Reuters) – The U.S. Food and Drug Administration on Friday approved Amgen Inc’s biosimilar version of AbbVie’s top-selling arthritis drug, Humira.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=897UvU5_F50:NWH33kZ_iAM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=897UvU5_F50:NWH33kZ_iAM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=897UvU5_F50:NWH33kZ_iAM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=897UvU5_F50:NWH33kZ_iAM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=897UvU5_F50:NWH33kZ_iAM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/897UvU5_F50
WASHINGTON (Reuters) – The U.S. Food and Drug Administration on Friday approved Amgen Inc’s biosimilar version of AbbVie’s top-selling arthritis drug, Humira.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=897UvU5_F50:NWH33kZ_iAM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=897UvU5_F50:NWH33kZ_iAM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=897UvU5_F50:NWH33kZ_iAM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=897UvU5_F50:NWH33kZ_iAM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=897UvU5_F50:NWH33kZ_iAM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/897UvU5_F50